Literature DB >> 6113617

Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats.

S E File.   

Abstract

Acute administration of lorazepam (0.25 and 0.5 mg/kg) and triazolam (0.075-0.25 mg/kg) significantly reduced the locomotor activity of rats placed in a holeboard for 10 min. Acute injections of lorazepam (0.25 and 0.5 mg/kg) and triazolam (0.05-0.25 mg/kg) also significantly reduced exploration, measured by the number of head-dips and the time spent head-dipping. After 3 days of pretreatment, tolerance developed to the sedative effects of these drugs: lorazepam (0.25 mg/kg) and triazolam (0.05 and 1 mg/kg) were without significant effect, and lorazepam (0.5 mg/kg) had only the effect of half that dose given acutely. Some of this behavioural tolerance could be attributed to changes in drug metabolism, and the development of tolerance did not require continuous presence of drug in brain and plasma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113617     DOI: 10.1007/bf00422410

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Effect of diazepam and chlordiazepoxide on the metabolism of other drugs.

Authors:  A Jori; P E Prestini; C Pugliatti
Journal:  J Pharm Pharmacol       Date:  1969-06       Impact factor: 3.765

2.  Tolerance development with chlordiazepoxide in relation to the plasma levels of the parent compound and its main metabolites in mice.

Authors:  J D Christensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1973

3.  Interactions of benzodiazepines with warfarin.

Authors:  M Orme; A Breckenridge; R V Brooks
Journal:  Br Med J       Date:  1972-09-09

4.  Increase of "antianxiety" activity and tolerance of behavioral depression during chronic administration of oxazepam.

Authors:  D L Margules; L Stein
Journal:  Psychopharmacologia       Date:  1968

5.  Physiological and psychological effects of clorazepate in man.

Authors:  M H Lader; S Curry; W J Baker
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

6.  A comparative study of certain pharmacologic responses following acute and chronic administrations of chlordiazepoxide.

Authors:  M E Goldberg; A A Manian; D H Efron
Journal:  Life Sci       Date:  1967-03-01       Impact factor: 5.037

7.  Metabolism and tolerance studies with chlordiazepoxide-2-l4C in the rat.

Authors:  D R Hoogland; T S Miya; W F Bousquet
Journal:  Toxicol Appl Pharmacol       Date:  1966-07       Impact factor: 4.219

8.  The reliability of the hole-board apparatus.

Authors:  S E File; A G Wardill
Journal:  Psychopharmacologia       Date:  1975-10-14

9.  Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain.

Authors:  C D Wise; B D Berger; L Stein
Journal:  Science       Date:  1972-07-14       Impact factor: 47.728

10.  Can social interaction be used to measure anxiety?

Authors:  S E File; J R Hyde
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

View more
  20 in total

1.  Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models.

Authors:  M Bourin; M Hascoet; B Mansouri; M C Colombel; J Bradwejn
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

2.  Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties.

Authors:  S E File; J Dingemanse; H L Friedman; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

4.  Behavioural responses to diazepam of drug-naive and experienced monkeys (Macaca mulatta).

Authors:  C M Bradley; A N Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man.

Authors:  K Aranko; M J Mattila; T Seppälä
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

6.  Abuse potential of benzodiazepines.

Authors:  D A Ciraulo
Journal:  Bull N Y Acad Med       Date:  1985-10

7.  Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.

Authors:  P Chopin; M B Assié; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Long-lasting single-dose tolerance to neurologic deficits induced by diazepam.

Authors:  S A Henauer; E J Gallaher; L E Hollister
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance.

Authors:  S E File
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Functional tolerance to lorazepam in the rat.

Authors:  R G Lister; S E File; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.